These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 9006525)

  • 21. Effect of early versus late administration of human recombinant erythropoietin on transfusion requirements in premature infants: results of a randomized, placebo-controlled, multicenter trial.
    Donato H; Vain N; Rendo P; Vivas N; Prudent L; Larguía M; Digregorio J; Vecchiarelli C; Valverde R; García C; Subotovsky P; Solana C; Gorenstein A
    Pediatrics; 2000 May; 105(5):1066-72. PubMed ID: 10790464
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet Transfusion Practices Among Very-Low-Birth-Weight Infants.
    Sparger KA; Assmann SF; Granger S; Winston A; Christensen RD; Widness JA; Josephson C; Stowell SR; Saxonhouse M; Sola-Visner M
    JAMA Pediatr; 2016 Jul; 170(7):687-94. PubMed ID: 27213618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Variations in blood transfusions among newborn intensive care units. SNAP II Study Group.
    Bednarek FJ; Weisberger S; Richardson DK; Frantz ID; Shah B; Rubin LP
    J Pediatr; 1998 Nov; 133(5):601-7. PubMed ID: 9821414
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacodynamically optimized erythropoietin treatment combined with phlebotomy reduction predicted to eliminate blood transfusions in selected preterm infants.
    Rosebraugh MR; Widness JA; Nalbant D; Cress G; Veng-Pedersen P
    Pediatr Res; 2014 Feb; 75(2):336-42. PubMed ID: 24216541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of transfusions in extremely low birth weight infants: a retrospective study.
    Valieva OA; Strandjord TP; Mayock DE; Juul SE
    J Pediatr; 2009 Sep; 155(3):331-37.e1. PubMed ID: 19732577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phlebotomy overdraw in the neonatal intensive care nursery.
    Lin JC; Strauss RG; Kulhavy JC; Johnson KJ; Zimmerman MB; Cress GA; Connolly NW; Widness JA
    Pediatrics; 2000 Aug; 106(2):E19. PubMed ID: 10920175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of erythropoietin on the transfusion requirements of preterm infants weighing 750 grams or less: a randomized, double-blind, placebo-controlled study.
    Ohls RK; Harcum J; Schibler KR; Christensen RD
    J Pediatr; 1997 Nov; 131(5):661-5. PubMed ID: 9403642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recombinant erythropoietin and blood transfusion in selected preterm infants.
    Meyer MP; Sharma E; Carsons M
    Arch Dis Child Fetal Neonatal Ed; 2003 Jan; 88(1):F41-5. PubMed ID: 12496225
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. European Multicentre Erythropoietin Study Group.
    Maier RF; Obladen M; Scigalla P; Linderkamp O; Duc G; Hieronimi G; Halliday HL; Versmold HT; Moriette G; Jorch G
    N Engl J Med; 1994 Apr; 330(17):1173-8. PubMed ID: 8139627
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant human erythropoietin and blood transfusion in low-birth weight preterm infants under restrictive transfusion guidelines.
    Badiee Z; Pourmirzaiee MA; Kelishadi R; Naseri F
    Saudi Med J; 2006 Jun; 27(6):817-20. PubMed ID: 16758042
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of High-Dose Erythropoietin on Blood Transfusions in Extremely Low Gestational Age Neonates: Post Hoc Analysis of a Randomized Clinical Trial.
    Juul SE; Vu PT; Comstock BA; Wadhawan R; Mayock DE; Courtney SE; Robinson T; Ahmad KA; Bendel-Stenzel E; Baserga M; LaGamma EF; Downey LC; O'Shea M; Rao R; Fahim N; Lampland A; Frantz ID; Khan J; Weiss M; Gilmore MM; Ohls R; Srinivasan N; Perez JE; McKay V; Heagerty PJ;
    JAMA Pediatr; 2020 Oct; 174(10):933-943. PubMed ID: 32804205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of a restricted transfusion schedule with erythropoietin therapy versus a restricted transfusion schedule alone in very low birth weight premature infants.
    Birenbaum HJ; Pane MA; Helou SM; Starr KP
    South Med J; 2006 Oct; 99(10):1059-62. PubMed ID: 17100024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changing patterns of red blood cell transfusion in very low birth weight infants.
    Widness JA; Seward VJ; Kromer IJ; Burmeister LF; Bell EF; Strauss RG
    J Pediatr; 1996 Nov; 129(5):680-7. PubMed ID: 8917234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of erythropoietin in premature infants.
    Amin AA; Alzahrani DM
    Saudi Med J; 2002 Mar; 23(3):287-90. PubMed ID: 11938417
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison between two and five doses a week of recombinant human erythropoietin for anemia of prematurity: a randomized trial.
    Brown MS; Keith JF
    Pediatrics; 1999 Aug; 104(2 Pt 1):210-5. PubMed ID: 10428996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic physiologic instability is associated with neurodevelopmental morbidity at one and two years in extremely premature infants.
    Mattia FR; deRegnier RA
    Pediatrics; 1998 Sep; 102(3):E35. PubMed ID: 9724683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Erythropoietic response to endogenous erythropoietin in premature very low birth weight infants.
    Freise KJ; Widness JA; Veng-Pedersen P
    J Pharmacol Exp Ther; 2010 Jan; 332(1):229-37. PubMed ID: 19808699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Red blood cell transfusions are independently associated with intra-hospital mortality in very low birth weight preterm infants.
    dos Santos AM; Guinsburg R; de Almeida MF; Procianoy RS; Leone CR; Marba ST; Rugolo LM; Fiori HH; Lopes JM; Martinez FE;
    J Pediatr; 2011 Sep; 159(3):371-376.e1-3. PubMed ID: 21489555
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of fresh red blood cell transfusions on clinical outcomes in premature, very low-birth-weight infants: the ARIPI randomized trial.
    Fergusson DA; Hébert P; Hogan DL; LeBel L; Rouvinez-Bouali N; Smyth JA; Sankaran K; Tinmouth A; Blajchman MA; Kovacs L; Lachance C; Lee S; Walker CR; Hutton B; Ducharme R; Balchin K; Ramsay T; Ford JC; Kakadekar A; Ramesh K; Shapiro S
    JAMA; 2012 Oct; 308(14):1443-51. PubMed ID: 23045213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Introduction of a donor exposure reduction programme for multiple-transfused very-low-birth-weight infants.
    Kirsten GF; Kirsten CL; Faber M; Collett C; Mitchell CA; Bird AR
    S Afr Med J; 1996 Nov; 86(11 Suppl):1460-4. PubMed ID: 9180796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.